# An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

> **NCT07678177** · — · RECRUITING · sponsor: **HK inno.N Corporation** · enrollment: 5384 (estimated)

## Conditions studied

- GERD (Gastroesophageal Reflux Disease)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07678177
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 5384 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07678177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07678177, "An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07678177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*